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HeartTransgenic mice overexpressing SUR2A, a subunit of ATP-sensitive K+ (KATP) channels, acquire resistance to
myocardial ischaemia. However, the mechanism of SUR2A-mediated cytoprotection is yet to be fully
understood. Adenoviral SUR2A construct (AV-SUR2A) increased SUR2A expression, number of KATP channels
and subsarcolemmal ATP in glycolysis-sensitive manner in H9C2 cells. It also increased K+ current in
response to chemical hypoxia, partially preserved subsarcolemmal ATP and increased cell survival.
Kir6.2AFA, a mutant form of Kir6.2 with largely decreased K+ conductance, abolished the effect of SUR2A
on K+ current, did not affect SUR2A-induced increase in subsarcolemmal ATP and partially inhibited SUR2A-
mediated cytoprotection. Infection with 193gly-M-LDH, an inactive mutant of muscle lactate dehydrogenase,
abolished the effect of SUR2A on K+ current, subsarcolemmal ATP and cell survival; the effect of 193gly-M-
LDH on cell survival was signiﬁcantly more pronounced than those of Kir6.2AFA. We conclude that AV-
SUR2A increases resistance to metabolic stress in H9C2 cells by increasing the number of sarcolemmal KATP
channels and subsarcolemmal ATP.s/MACHS, Ninewells Hospital
1 9SY, Scotland, UK. Tel.: +44
ović).
 license.© 2010 Elsevier B.V. Open access under CC BY license.1. Introduction
Cardiac sarcolemmal ATP-sensitive K+ (KATP) channels are gated
by intracellular ATP and are viewed as a link between cellular
metabolism and membrane excitability. These channels are closed
under physiological conditions and are opened only during ischaemia,
which protect the myocardium against ischaemic damage. Structur-
ally, sarcolemmal KATP channels in vivo are composed of an inward
rectiﬁer, Kir6.2 and Kir6.1, SUR2A, an ATP-binding protein, and
accessory proteins that are glycolytic and ATP-producing enzymes
[reviewed in 1]. Recently, it has been shown that cardiomyocytes from
transgenic mice overexpressing KATP channel regulatory subunit,
SUR2A, acquire resistance against hypoxia and other types of
metabolic stresses. The mechanism of SUR2A-mediated cardioprotec-
tion seems to be associated with increased numbers of sarcolemmal
KATP channels, earlier activation of KATP channels during stress,
shortening of the action membrane potential and consequent
decrease in Ca2+ inﬂux [2]. It should be, however, said that in some
recent studies a mechanism of cytoprotection afforded by KATP
channels independent from the channel activity was reported. More
speciﬁcally, it has been suggested that enzymes that are physically
associated with KATP channel subunits regulate subsarcolemmal/
intracellular ATP levels, which, in turn, promotes cellular survivalunder metabolic stress [3-5]. It is therefore possible that SUR2A-
mediated cardioprotection has a component in addition to the
increased channel activity.
Therefore, we have undertaken this research to elucidate the
channel-dependent and channel-independentmechanisms of SUR2A-
mediated cytoprotection. It has been shown that rat heart embryonic
H9C2 cells are good experimental model to study SUR2A, KATP
channels and cardioprotection [6]. As an example, these cells have
been used to uncover the effect of increased SUR2A expression on
cellular response to metabolic stress [7,8], which was shown to
correspond to adult hearts exposed to hypoxia [2]. Here, we have
generated adenovirus containing gene encoding SUR2A and tested the
effect that this construct has on survival of H9C2 cells exposed to
severe metabolic stress. We have elucidated the mechanism under-
lying SUR2A-mediated cytoprotection and found out that there is
more to the cardioprotection by SUR2A than previously thought.
2. Methods
2.1. H9C2 cells and viral constructs
H9C2 cell rat embryonic heart H9c2 cells (ECACC, Salisbury, UK)
were cultured in a tissue ﬂask (at 5% CO2) containing Dulbecco's
modiﬁed Eagle's medium supplemented with 10% fetal calf serum and
2 mM glutamine. For electrophysiological experiments, the cells were
plated on a 35×10-mm culture dish containing 25-mm glass cover-
slips. The cells were cultured in incubators (Galaxy, oxygen control
model, RS Biotech, Irvine, UK). For the experiments H9C2 cells were
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cent protein (GFP, gift from C. Sunderland, University of Dundee; cells
infected with GFP have served as control cells in this study), gly193-
M-LDH (a catalytically inactive mutant of M-LDH, [9], Kir6.2, or
Kir6.2AFA (a mutant form of Kir6.2 where the pore GFG was mutated
into AFA leading to largely reduced K+ conductance, [10]). When
intracellular and subsarcolemmal ATP levels were measured cells
were infected with adenovirus containing luciferase and annexin VI-
luciferase genes respectively. All these adenoviruses were generated
and used as described in details in [4,5]. The recombinant SUR2A
adenovirus (AV-SUR2A) was generated using the AdEasy XL Adeno-
viral Vector System (Stratagene). SUR2A gene was cloned into a
shuttle vector pShuttle-CMV by PCR using the following primers
containing restrict enzyme sites Bgl II/Xho I, sense, 5′-GCAGATCT GGC
AGG CTG TTG GTA GCT CA-3′, antisense, 5′-GCCTCGAG CTA CTT GTT
GGT CAT CAC CA-3. The positive clones containing DNA inserts were
linearized with Pme I and transformed into BJ5183-AD-1 competent
cells to perform homologous recombination in Escherichia coli
between the shuttle vectors carrying SUR2A gene and a large
adenovirus containing plasmid following electroporation. Recombi-
nants were identiﬁed from single colonies, linearized, and then
transfected into HEK293 cells to produce infective adenovirus virions.
Adenoviral particles were obtained by cell extraction after 7–10 days
of transfection, and the primary virus was further ampliﬁed by
infection of AD-293 cultures, ampliﬁed virus stock is prepared by 4
rounds of freeze/thaw. The virus titer is determined using QuickTiter
Adenovirus Titer Immunoassay Kit (Cell Biolabs, Inc) according to the
manufacturer's instructions. To infect H9C2 cells, a solution of
recombinant adenovirus was mixed with culture medium, and cells
were exposed to the virus with a multiplicity of 10 viral particles/cell
for 48 h.
2.2. Real time RT-PCR
Total RNA was extracted from heart of rat H9C2 cells using TRIZOL
reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's
recommendations. Extracted RNAwas further puriﬁed by RNeasy Plus
Mini Kit (Qiagen, Crawley, UK) according to the manufacturer's
instructions. Rat primers for all KATP channel subunits were designed
as depicted on Table 1. All KATP channel subunits weremeasured using
these primers apart on SUR2A that was measured by combining
SUR2A rat (Table 1) and mouse (sense: ACTATGGAGTCCGAGAACTA,
antisense: AGGTTTGGACCAGTATCACA) primers. The structural sim-
ilarity between mouse and rat SUR2A is 93%, but the primers used for
mouse SUR2A do not recognize RAT SUR2A and vice versa. Therefore,
we have used mouse SUR2A to make adenoviral construct, so that we
can examine the level of adenoviral SUR2A expression in host H9C2
cells. To measure total SUR2A mRNA levels we have combined both
sets of primers. The reverse transcription (RT) reaction was carried
out with ImProm-II Reverse Transcriptase (Promega, Southampton,
UK). A ﬁnal volume of 20 µl of RT reaction containing 4 µl of 5× buffer,
3 mMMgCl2, 20 U of RNasin® Ribonuclease inhibitor, 1 U of ImProm-
II reverse transcriptase, 0.5 mM each of dATP, dCTP, dGTP, and dTTP,
0.5 µg of oligo(dT), and 1 µg of RNAwas incubated at 42 °C for 1 h andTable 1
Rat primers used in real time RT-PCR experiments.
mRNA Sense Antisense
SUR 1 5′-GGAAGGACTC ACCACCATC-3′ 19 bp 5′-GAGACCA
SUR2A 5′-ACTTCAGCGT TGGACAGAGAC-3′ 21 bp 5′-AGCAGGT
SUR2B 5′-GACGCCA CTGTCACCGAAG-3′ 19 bp 5′-TCATCACA
Kir6.1 5′-GTCACACGCTG GTCATCTTCAC-3′ 22 bp 5′-GGCACTCC
Kir6.2 5′-TGGCTGACGAG ATTCTGTGG-3′ 20 bp 5′-TGGCGGG
GAPDH 5′-ATAGAATTCC ATGACAAAGTGGAC ATTGTTGCCA-3′ 34 bp AGCCTCGAGTthen inactivated at 70 °C for 15 min. The resulting cDNAwas used as a
template for real time PCR. A SYBR Green I systemwas used for the RT-
PCR and the 25 µl reaction mixture contained: 12.5 µl of iQ™ SYBR®
Green Supermix (2×), 7.5 nM each primers, 9 µl of ddH2O, and 2 µl of
cDNA. In principle, the thermal cycling conditions were as follows: an
initial denaturation at 95 °C for 3 min, followed by 40 cycles of 10 s of
denaturing at 95 °C, 15 s of annealing at 56 °C, and 30 s of extension at
72 °C. The real time PCR was performed in the same wells of a 96-well
plate in the iCycler iQ™Multicolor Real-Time Detection System (Bio-
Rad, Hercules, CA). Data was collected following each cycle and
displayed graphically (iCycler iQ™ Real-Time Detection System
Software, version 3.0A, Bio-Rad, Hercules, CA). Primers were tested
for their ability to produce no signal in negative controls by dimer
formation and then with regard to the efﬁciency of the PCR reaction.
Efﬁciency is evaluated by the slope of the regression curve obtained
with several dilutions of the cDNA template. Melting curve analysis
tested the speciﬁcity of primers. Threshold cycle values, PCR efﬁciency
(examined by serially diluting the template cDNA and performing PCR
under these conditions) and PCR speciﬁcity (by constructing the
melting curve) were determined by the same software. Each mouse
cDNA sample was measured at three different quantities (and
duplicated at each concentration, the corresponding no-RT mRNA
sample was included as a negative control (blank). To determine
relativemRNA expression (normalised to the wild type) we have used
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a control
gene. The calculation of relative mRNA expression was performed as
described [11]. The relative expression ratio (R) of SUR2A is calculated
using equation R=(EK)ΔCPK(WT-TG)/(ER)ΔCPR(WT-TG) where EK is the real
time PCR efﬁciency of SUR2A gene transcript, ER is the real time PCR
efﬁciency of GAPDH gene, ΔCPK is the crossing point deviation of wild
type-transgene (infected) of SUR2A gene transcript while ΔCPR is the
crossing point deviation of wild type-transgene of GAPDH gene
transcript.
2.3. Patch clamp electrophysiology
To monitor whole cell K+ current the gigaohm seal patch clamp
technique was applied in the perforated-patch whole cell conﬁgura-
tion. H9C2 cells were superfused with Tyrode solution (in mM: 136.5
NaCl; 5.4 KCl; 1.8 CaCl2; 0.53 MgCl2; 5.5 glucose; 5.5 HEPES-NaOH; pH
7.4). All pipettes (resistance 3–5 MΩ), were ﬁlled with (in mM): KCl
140, MgCl2 1, HEPES-KOH 5 and amphotericin B (Sigma, 240 μg/ml)
(pH 7.3). For all cells monitored, the membrane potential was
normally held at −40 mV and the currents evoked by a series of
400 ms depolarising and hyperpolarising current steps (−100 mV to
+80 mV in 20 mV steps) recorded directly to hard disk using
an Axopatch-200B ampliﬁer, Digidata-1321 interface and pClamp8
software (Axon Instruments, Inc., Forster City, CA). The capacitance
compensation was adjusted to null the additional whole cell
capacitative current. The slow capacitance component measured by
this procedure was used as an approximation of the cell surface area
and allowed normalisation of current amplitude (i.e. current density).
Currents were low pass ﬁltered at 2 kHz and sampled at 100 μs
intervals.PCR product
TC AAGGCATAGG-3′ 19 bp 252 bp
TTGG ACCAGTATCG-3′ 21 bp 259 bp
ATG ACCAGGTCAGC-3′ 22 bp 244 bp for SUR2B 420 bp for SUR2A
TCAG TCATCATTCTCC-3′ 24 bp 249 bp
GCTG TGCAGAG-3′ 17 bp 130 bp
TA GGAAATGAG CTTCACAAAGTT-3′ 33 bp 860 bp
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The survival of H9C2 cells was assayed using Multitox-Fluor
Multiplex Cytotoxicity Assay (Promega). Brieﬂy, H9C2 cells were
plated in complete media (DMEM containing 10% FCS) in 96-well
plate, the recombinant adenovirus (GFP as a control or other
adenoviruses as stated in the Results section) was added to the
wells at the multiplicity of infection of 10. After a 48 h infection, the
DNP was added to each well at the ﬁnal concentration of 10 mM. To
measure cell survival 6 h later, the peptide substrate (GF-AFC) that
can be cleaved only by live cells was added to the each well. Following
a 30 min-long incubation at 37 °C, plates were measured using 1420
Multibabel Counter (Victor) plate reader, with excitation at 370 nm
and emissions of 480 nm. The percentage of live cells was calculatedFig. 1. Infection with AV-SUR2A increases expression of SUR2A without affecting the expres
time RT-PCR progress curves of KATP channel-forming subunits. Inset in SUR2A graph is a W
anti-GAPDH antibody under depicted conditions (for SUR2 the signal depicted was betwe
Prestained Standard, Invitrogen; similar results were obtained in three independent experibased on the intensity of ﬂuorescence according to themanufacturer's
instructions.
2.5. Luciferase assay
H9C2 cells were co-infected with adenoviruses containing genes
encoding luciferase (to measure total ATP) or annexin-luciferase (to
measure subsarcolemmal ATP) together with adenoviruses contain-
ing genes encoding KATP channel-forming proteins (as named in the
Results section) 48 h before luciferase assay. To measure luciferase
luminescence cells were mounted in 96-well plate in buffer with the
following composition (in mM): 30 HEPES, 3 ATP, 15 MgSO4, 10 DTT;
pH: 7.4. Some of the cells were untreated while the others were
treated with 10 mM DNP. The reaction for luciferase luminescencesion of other KATP channel subunits. Bar graphs represent cycling thresholds of the real
estern blot of anti-Kir6.2 immunoprecipitate from H9C2 cells with either anti-SUR2 or
en 97 and 191 kDa while for GAPDH it was ∼39 kDa as determined by SeeBlue Plus
ments). Each bar represents mean±SEM (n=4 for each). *Pb0.05.
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luminescence was measured on a plate reader 1420 Multibabel
Counter (Victor). Luminescence was measured in the absence of DNP
and after 1 h of cell incubation with 10 mM DNP. To validate that
annexin-luciferase- and luciferase-mediated signal reﬂect subsarco-
lemmal and cytosolic ATP respectively, cells were infected with either
luciferase, annexin-luciferase or GFP (control), harvested after 48 h
and plasma membrane and cytosolic fractions were obtained as
described in [7]. The presence/absence of plasma membrane in a
fraction was veriﬁed by 5-nucleotidase assay. Luminescence was
measured as described above; in membrane and cytosolic fractions
(both spikedwith 5 mMATP) of cells infectedwith annexin-luciferase
the luminescence signal was 6956 AU/mg protein and 480 AU/mg
protein respectively. These results demonstrated that targeted
expression of luciferase to membrane was successful and that signal
in vivo reﬂects mostly the level of ATP in environment surrounding
the plasma membrane. On the other hand, in cells infected with
luciferase, luminescence was 1030 AU/mg protein in cytosolic
fraction and 670 AU/mg protein in membrane fraction showing
ubiquitous distribution of luciferase.
2.6. Immunoprecipitation/Western blotting
The cells were homogenised in buffer (TRIS 10 mM, NaH2PO4
20 mM, EDTA 1 mM, PMSF 0.1 mM, pepstatin 10 μg/ml, leupeptin
10 μg/ml, at pH=7.8) and centrifugated at 500 g (to remove large
particles from the homogenate). To obtain cellular membrane fraction
cells were homogenised in buffer I (TRIS 10 mM, NaH2PO4 20 mM,
EDTA 1 mM, PMSF 0.1 mM, pepstatin 10 μg/ml, leupeptin 10 μg/ml, at
pH=7.8) and incubated for 20 min (at 4 °C). The osmolarity was
restored with KCl, NaCl and sucrose and the obtained mixture was
centrifugated at 500 g. The supernatant was diluted in buffer II
(imidazole 30 mM, KCl 120 mM, NaCl 30 mM, NaH2PO4 20 mM,Fig. 2. Infection with AV-SUR2A increases DNP-induced whole cell K+ current. Original me
scatter graph showing DNP-induced K+ current component (obtained by substraction of w
cells infected with AV-SUR2A (SUR2A). Each point represents mean±SEM (n=5 for each)sucrose 250 mM, pepstatin 10 μg/ml, leupeptin 10 μg/ml, at pH=
6.8) and centrifugated at 7000 g, pellet removed and supernatant
centrifugated at 30000 g. The obtained pellet contains membrane
fraction. Protein concentration was determined using the method of
Bradford; 10 µg of the anti-Kir6.2 antibodywas prebound to Protein-G
Sepharose beads and used to immunoprecipitate from 50 µg of
membrane fraction protein extract. The pellets of this precipitation
were run on SDS-polyacrylamide gels for Western analysis. Western
blot probing was performed using 1/1000 dilution of anti-SUR2 or
anti-LDH antibody, respectively, and detection was achieved using
Protein-G HRP and ECL reagents. The band intensities were analysed
using the Quantiscan software.
2.7. Statistical analysis
Data are presented as mean±SEM, with n representing the
number of independent experiments. Mean values were compared
by the ANOVA followed by Student's t-test or by Student's t-test alone
where appropriate using SigmaStat program (Jandel Scientiﬁc,
Chicago, Illinois). Pb0.05 was considered statistically signiﬁcant.
3. Results
3.1. Infection with SUR2A increases the level of SUR2A in H9C2 cells
We have analysed levels of SUR2A mRNA in control cells and cells
infected with AV-SUR2A using real time RT-PCR. This method has
revealed that infection with AV-SUR2A has signiﬁcantly increased
mRNA levels of SUR2A (cycling threshold was 23.20±0.10 in control
cells and 21.05±0.05 in infected cells, n=4 for each, Pb0.01, Fig. 1).
No statistically signiﬁcant difference was observed in mRNA levels of
other KATP channel-forming subunits (Fig. 1). It is estimated that
infected cells had 4.22 timesmore SUR2AmRNA than the control cells.mbrane currents under depicted conditions (DNP concentration was 10 mM) and line-
hole cell K+ current in the presence and absence of DNP) in control cells (control) and
.
Fig. 3. Infection with AV-SUR2A increases survival of cells exposed to DNP. A bar graph
showing a percentage of survival in control cells and cells infected with SUR2A alone,
Kir6.2 alone or SUR2A/Kir6.2 exposed to DNP (10 mM). Each bar represent mean
±SEM (n=3–14). *Pb0.05 when compared to control.
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extract with anti-SUR2 antibody. Using this strategy, we measured
only those Kir6.2 and SUR2A subunits that physically assemble in
sarcolemma to form a channel. Western blot has demonstrated that
the level of myocardial SUR2A protein was increased in H9C2 cells in
comparison to control cells (Fig. 1). Another protein known to be a
part of the sarcolemmal KATP channel protein complex, GAPDH [12],
was also increased in cell infected with SUR2A (Fig. 1).
It is well established that KATP channels are activated when cardiac
cells are challenged with 2.4-dinitrophenol (DNP). This channel
activation is cellular self-protectivemechanism as it hyperpolarize the
membrane, inhibits inﬂux of Ca2+ and counteracts DNP-inducedFig. 4. Kir6.2AFA abolishes SUR2A-mediated increase in K+ current. Original membrane curr
showing DNP-induced K+ current component (obtained by substraction of whole cell K+ cur
AV-SUR2A plus AV-Kir6.2AFA. Each point represents mean±SEM (n=4 for each).cellular damage [13–16]. We have applied perforated patch clamp
electrophysiology to test whether infection with AV-SUR2A has any
effect on DNP-induced whole cell K+ current. Perforated patch whole
cell recording does not impair intracellular milieu [17], which allows
monitoring the behaviour of KATP channels-conducted K+ current
during stress under conditions of intact intracellular environment. In
control cells, exposure to DNP (10 mM) has induced a signiﬁcant
increase in whole cell K+ current ﬂowed through KATP channels [see
also 4,5], but this was more pronounced in cells infected with SUR2A
(Fig. 2).
3.2. Infection with SUR2A increase cellular resistance to severe metabolic
stress
DNP is known metabolic inhibitor that is used to induce metabolic
stress in different cell types [18].When control cells were treatedwith
DNP (10 mM), only 43.3±1.8% (n=14) of cells have survived this
insult (Fig. 3). Cells infected with SUR2A were signiﬁcantly more
resistant to DNP (10 mM) than control cells (58.9±2.0% of cells
infected with SUR2A have survived DNP, n=8, Pb0.001 when
compared to the control, Fig. 3). On the other hand, infection with
Kir6.2 alone did not have any effect on cellular survival under DNP
(10 mM; 45.9%±2.6%, n=3, P=0.93 when compared to the control
cells, Fig. 3) neither infection with SUR2A/Kir6.2 improved the effect
of SUR2A alone (53.2%±4.1%, n=3, P=0.28 when compared with
cells infected with SUR2A alone, Fig. 3).
3.3. Infection with Kir6.2AFA abolishes DNP-induced K+ current in
control and cells infected with SUR2A
Kir6.2AFA is a mutant Kir6.2 form with largely reduced ability to
conduct K+. When Kir6.2AFA is introduced into H9C2 cells DNP does
not induce increase in K+ current, which is in agreement with notion
that treatment with DNP activates sarcolemmal KATP channels [4,5]. In
cells infected with SUR2A/Kir6.2AFA DNP did not induce increase in
whole cell K+ current (Fig. 4).ents under depicted conditions (DNP concentration was 10 mM) and line-scatter graph
rent in the presence and absence of DNP) in cells infected with AV-SUR2A (SUR2A) and
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effect
In cells infected with Kir6.2AFA alone, survival rate in 10 mMDNP-
treated cells was 39.1±1.4% (n=6) and that was slightly, but
signiﬁcantly, lower than survival of the control cells (43.3±1.8%,
n=14; Fig. 5). A concomitant infection of H9C2 cells with SUR2A and
Kir6.2AFA has resulted in cell survival of 47.3±1.2% (n=5), which
was signiﬁcantly lower than survival in cells infected with SUR2A
(58.9±2.0%, n=8, Pb0.01), but signiﬁcantly higher than survival in
cells infected with Kir6.2AFA alone (47.3±1.2% with Kir6.2AFA/
SUR2A n=5, Pb0.001 when compared to Kir6.2AFA cells, Fig. 5).
3.5. Infection with SUR2A increases levels of subsarcolemmal ATP in
H9C2 cells
Sarcolemmal KATP channel complex seems to contain, besides the
channel subunits, glycolytic and other enzymes that catalyses
reactions producing ATP [9,12,19–22]. Anything that would increase
the levels of ATP would improve cellular well being under different
conditions of stress. Therefore, we have tested the levels of
intracellular and subsarcolemmal ATP using luciferase and annexin-
luciferase constructs respectively. Infection of SUR2A did not
signiﬁcantly change intracellular level of ATP (the intensity of
luciferase luminescence was 144.8±5.3 AU in control and 142.8±
8.9 AU in SUR2A cells, n=5, P=0.85, Fig. 6). However, infection with
SUR2A did increase subsarcolemmal levels of ATP (the intensity of
annexin-luciferase luminescence was 204.8±9.0 AU in control and
284.6±20.4 AU in SUR2A cells, n=5, P=0.01, Fig. 6). After treatment
with DNP (10 mM) total intracellular ATP levels were not different in
control cells and cells infected with SUR2A (the intensity of luciferase
luminescence was 57.6±2.4 AU in control cells and 63.0±2.5 AU in
SUR2A cells, n=5, P=0.16, Fig. 6). In contrast, subsarcolemmal ATP
levels were signiﬁcantly increased in SUR2A-infected cells (the
intensity of annexin-luciferase luminescence was 71.8±2.1 AU in
control cells and 96.8±2.4 AU in SUR2A cells, n=5, Pb0.001, Fig. 6).
An increased ATP levels in subsarcolemmal space would be in accord
with the idea that enzymes physically associated with the KATP channel
subunits produceATPand that infectionwith SUR2A increasesnumber of
ATP-producing KATP channel protein complexes [4,5]. So far, ﬁve
glycolytic enzymeswere identiﬁed as parts of sarcolemmal KATP channel
protein complex [9,10,22]. Here, to test whether SUR2A-mediatedFig. 5. Kir6.2AFA only partially inhibits SUR2A-mediated cytoprotection. A bar graph
showing a percentage of survival in cells infected with Kir6.2AFA alone, Kir6.2AFA/
SUR2A and SUR2A alone exposed to DNP (10 mM). Each bar represent mean±SEM
(n=5–14). *Pb0.05 when compared to the control.increase in subsarcolemmal ATP is associated with glycolysis, we have
examine the effect of 2-deoxyglucose on SUR2A-mediated increase in
cytosolic and subsarcolemmal ATP. 2-deoxyglucose (50 mM) blocked
the effect of SUR2A on subsarcolemmal ATP (the intensity of annexin-
luciferase luminescencewas241.6±11.1 AU in control cells and212.2±
12.8 AU in SUR2A cells, n=5, P=0.12, Fig. 6). SUR2A also did not affect
intracellular ATP levels in cells treated by 2-deoxyglucose (50 mM; the
intensity of luciferase luminescence was 154.4±10.8 AU in control cells
and 151.0±5.2 AU in SUR2A cells, n=5, P=0.78, Fig. 6).
3.6. Expression of Kir6.2AFA does not modify effect of SUR2A on ATP
levels
It is already known that infection with Kir6.2AFA per se does not
affect either total or subsarcolemmal ATP levels [4]. When Kir6.2AFA
cells were infected with SUR2A no changes in intracellular ATP was
observed (the intensity of luminescence was 494.0±31.2 AU in
Kir6.2AFA and 493.6±59.7 AU in Kir6.2AFA/SUR2A cells, n=5,
P=0.99, Fig. 7). However, infection with SUR2A has signiﬁcantly
increased the levels of subsarcolemmal ATP (the intensity of
luminescence was 688.2±140.7 AU in Kir6.2AFA and 1787.2±
148.9 AU in Kir6.2AFA/SUR2A cells, n=5, Pb0.001, Fig. 7). After
treatment with DNP (10 mM), intracellular ATP levels were also not
different between the cellular phenotypes (the intensity of lumines-
cence was 133.4±16.1 AU in Kir6.2AFA and 125.4±16.9 AU in
Kir6.2AFA/SUR2A cells, n=5, P=0.74, Fig. 7), as opposed to the
level of subsarcolemmal ATP that was signiﬁcantly increased in cells
infected with SUR2A (the intensity of luminescence was 114.3±
6.5 AU in Kir6.2AFA and 204.0±7.6 AU in Kir6.2AFA/SUR2A cells,
n=5, Pb0.001, Fig. 7).
3.7. 193glyM-LDH inhibits the effect of SUR2A on subsarcolemmal ATP
and DNP-induced K+ current
We have recently shown that 193glyM-LDH, a mutant form of
muscle lactate dehydrogenase (M-LDH) that has lost its catalytic
activity while retained the ability to physically interact with Kir6.2/
SUR2A, inhibits both DNP-induced KATP channel activation and ATP
production by sarcolemmal KATP channels [4]. In cells infected with
both SUR2A and 193glyM-LDH, DNP did not increase whole cell K+
current (Fig. 8A). The luciferase luminescence in cells infected with
both SUR2A and 193glyM-LDH was 176.6±22.8 AU (n=5) and that
was not signiﬁcantly different from those infected with SUR2A alone
where luciferase ﬂuorescence was 142.8±8.9 AU (n=5, P=0.23
when compared to SUR2A/193glyM-LDH cells, Fig. 8B). The annexin-
luciferase ﬂuorescence was 326.8±28.1 AU (n=5) in SUR2A/
193glyM-LDH cells which was signiﬁcantly lower than those in
SUR2A cells (annexin-luciferase ﬂuorescence was 496.4±45.8 in
SUR2A cells, P=0.01 when compared to SUR2A/193glyM-LDH cells,
n=5, Fig. 8B). Similar results were obtained when ATP levels were
measured after treatment with DNP (10 mM). For cells infected with
SUR2A alone, luciferase and annexin-luciferase ﬂuorescence were
64.8±6.6 AU and 91.4±9.9 AU respectively (n=5 for all; Fig. 8B).
Both of these values were signiﬁcantly higher than in cells infected
with SUR2A/193glyM-LDH (luciferase: 49.8±2.1 AU, n=5, Pb0.001
when compared to SUR2A cells; annexin-luciferase: 57.2±3.6 AU,
n=5, Pb0.001 when compared to SUR2A cells, Fig. 8B).
3.8. 193glyM-LDH inhibits SUR2A-mediated cytoprotection
193glyM-LDH has shown to simultaneously inhibit both mechan-
isms that could contribute to the SUR2A-mediated cytoprotection
(increase in subsarcolemmal ATP and increase in K+ current).
Therefore, we have assessed the effect that 193glyM-LDH has on
SUR2A-mediated cytoprotection. Cells co-infected with SUR2A/
193glyM-LDH were signiﬁcantly more sensitive to DNP (10 mM)
Fig. 6. Infection with AV-SUR2A increases the levels of subsarcolemmal ATP. Bar graphs showing luciferase (intracellular ATP) and annexin-luciferase (subsarcolemmal ATP)
luminescence in control cells and cells infected with AV-SUR2A under control conditions (control) and after treatment with either 10 mM DNP (DNP) or 50 mM 2-deoxyglucose
(2-deoxyglucose). Each bar represent mean±SEM (n=5). *Pb0.05.
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SUR2A/193glyM-LDH cells and 58.3±1.6% for SUR2A cells, n=3–6,
Pb0.001, Fig. 9) and cells co-infected with SUR2A/Kir6.2AFA (cell
survival was 47.3±1.6% in these cells, n=6, Pb0.001when compared
to SUR2A/193glyM-LDH cells).
4. Discussion
In the present study we have shown that SUR2A mediate
cardioprotection by increasing the numbers of sarcolemmal KATP
channels and consequent increase in K+ current and subsarcolemmal
ATP levels.
It has been previously shown that moderate increase in SUR2A
generates a myocardial phenotype with increased numbers of
sarcolemmal KATP channels and increased resistance to ischaemia–reperfusion [2]. In this particular phenotype SUR2A expression was
under control of CMV promoter, which is the promoter used in AV-
SUR2A in this study as well. Under CMV promoter SUR2A mRNA in
hearts of transgenic animals was increased for ∼6 times in
comparison to the wild type [2], which is similar to those in H9C2
cells achieved by AV-SUR2A. This modest up-regulation of SUR2A has
resulted in increased number of sarcolemmal KATP channels, which is
in accord to what has been observed in transgenic CMV-SUR2A
phenotype [2]. It should be mentioned that a transgenic phenotype
overexpressing SUR2A by action ofαMHCpromoter has decreased the
number of sarcolemmal KATP channels [23]. However, as opposed to
infected H9C2 cells, in the phenotype described by Flagg et al. mRNA
SUR2A levels were increased by ∼50 times. It has been reported that
cardiac Kir6.2 mRNA levels are physiologically ∼30 times higher than
those values of SUR2A [2]. How this transpose into difference at
Fig. 7. Kir6.2AFA does notmodify the effect of AV-SUR2A on ATP levels. Bar graphs showing luciferase (intracellular ATP) and annexin-luciferase (subsarcolemmal ATP) luminescence
in cells infected with kir6.2AFA alone and SUR2A/Kir6.2AFA under control conditions (control) and after treatment with 10 mMDNP (DNP). Each bar represent mean±SEM (n=5).
*Pb0.05.
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between protein levels also exist. It is therefore possible that
stimulating expression of SUR2A over the levels of Kir6.2 expression
would suppress the functional expression of KATP channels from
optimized dimeric SUR2A/Kir6.2. A similar idea about the regulation
of KATP channel numbers has been put forward by Flagg et al. [23] and
this could explain why a moderate, but not extreme, increase in
SUR2A levels results in increased number of sarcolemmal KATP
channels.
DNP is a known metabolic inhibitor that was used in many studies
to induce metabolic stress in different cell types [18]. When applied,
this compound induces chemical hypoxia, which activates KATP
channels [24]. In turn, such activation of the channels decreases a
degree of cell injury [13]. The ﬁnding that DNP-induced K+ current
was increased in cells infectedwith SUR2A is in accordwith these cells
having increased number of sarcolemmal KATP channels. An increase
in sarcolemmal KATP channels is associated with increased myocardial
resistance to metabolic stress [7,8,25]. However, there is a report
suggesting that a lack of SUR2A, but not Kir6.2 [26], generates a
cardiac phenotype with increased resistance to ischaemia/reperfu-
sion [27]. Most recently, this has been explained by the presence of a
short SUR2A form in mitochondria when it plays a cardioprotective
role that remained unaffected in SUR2A knockout phenotype [28]. On
the other hand, transgenic mice with moderately increased expres-
sion of SUR2A also acquire resistance to metabolic stress, which was
explained by increase in numbers of sarcolemmal KATP channels and
earlier channel activation in response to metabolic stress [2]. Here, we
have shown that an acute increase in SUR2A expression conferscytoprotection, which would be in accord with reports associating
increased SUR2A with the cardioprotective outcome [29].
The mechanism of cytoprotection afforded by KATP channels is a
long-standing issue. It is predominant view that the activation of the
channel is required for KATP channels to protect the heart against
metabolic stress [30]. How opening of sarcolemmal KATP channels
protect the heart against metabolic stress is still to be fully
understood. It is traditional view that the activation of KATP channels
shortens action membrane potential resulting in decreased inﬂux of
Ca2+ and prevention of Ca2+ overload [30]. However, it has been
shown that the activation of KATP channels is protective in cells that do
not generate action membrane potential, including diastolic cardio-
myocytes [14–16]. More recently, we have suggested that cytoprotec-
tion afforded by KATP channels could also involve a channel activity-
independent mechanism [4,5]. Speciﬁcally, it has been found that
inhibition of the catalytic activity of M-LDH, an enzyme physically
associated with sarcolemmal KATP channels [9], results in decreased
ATP levels as well as inhibited KATP channels-mediated K+ current in
response to stress. The inhibition of both the channel activity and ATP
production had much more pronounced effect on cell survival than a
sole inhibition of channel activity [4,5]. Based on these ﬁndings, it was
concluded that production of ATP by sarcolemmal KATP channel
protein complex is a signiﬁcant part of the mechanism underlying
KATP channel-mediated cardioprotection. In the present study, we
have shown that increase in SUR2A expression increases subsarco-
lemmal ATP levels even under control conditions. This would support
the notion that sarcolemmal KATP channel protein complex produces
ATP and that this property could be important even under
Fig. 8. 193gly-M-LDH inhibits effects of SUR2A on DNP-induced K+ current and ATP levels. A. Line-scatter graph showing DNP-induced K+ current component in cells infected with
AV-193gly-M-LDH in the absence (control) and presence of DNP (10 mM). Each point represents mean (n=4). B. Bar graphs showing luciferase (intracellular ATP) and annexin-
luciferase (subsarcolemmal ATP) luminescence in cells infected with SUR2A alone and SUR2A/193gly-M-LDH under control conditions (control) and after treatment with 10 mM
DNP (DNP). Each bar represent mean±SEM (n=5). *Pb0.05.
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shown that channel subunits in vivo are physically associated with
enzymes that catalyses ATP production, most of them being involved
in glycolysis [9,12,22]. Such composition of sarcolemmal KATP
channels would allow a supposition that KATP channel protein
complex could serve as ATP-producing machinery in the sarcolemma.
To test hypothesis that production of ATP by glycolytic enzymes
physically associated with KATP channel subunits mediates the effect
of SUR2A on subsarcolemmal ATP, we have used 2-deoxyglucose, a
known inhibitor of glycolysis. Treatment with this compound
abolished the effect of SUR2A on subsarcolemmal ATP showing thatglycolysis is essential for the observed SUR2A effect. This would be in
agreement with the idea that ATP produced by glycolytic enzymes
physically associated with KATP channel subunits underlies SUR2A-
mediated increase in subsarcolemmal ATP levels. The fact that SUR2A
counteracted DNP-induced loss of subsarcolemmal ATP further
supports our hypothesis that fully assembled KATP channel protein
complexes might serve as an ATP producer in vivo. It would be logical
to expect that more subsarcolemmal ATP would support ion
homeostasis by providing energy for active transport processes.
As opposed to Kir6.2AFA that inhibits KATP channels permeability
without affecting subsarcolemmal ATP levels, 193glyM-LDH has
Fig. 9. Infection with AV-SUR2A increases survival of cells exposed to DNP. A bar graph
showing a percentage of survival in cells infected with SUR2A alone, SUR2A/Kir6.2AFA
and SUR2A/193gly-M-LDH exposed to DNP (10 mM). Each bar represent mean±SEM
(n=3–6). *Pb0.05 when compared to SUR2A and +Pb0.05 when compared to SUR2A/
Kir6.2AFA.
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Lactate dehydrogenase (LDH) is a tetramer composed of either M
(muscle) and/or H (heart) subunits, which may be combined to form
ﬁve LDH isozymes. In the heart, all LDH isozymes are present; LDH1
(H4) is the predominant form, whereas LDH5 (M4) is present in trace
amounts [31]. It has been shown that M-LDH, but not H-LDH,
physically associates with Kir6.2 and SUR2A subunits and is integral
part of the sarcolemmal KATP channel protein complex [9]. DNP is a
known inhibitor of oxidative phosphorylation, but the mechanism of
DNP-induced activation of sarcolemmal KATP channels is less
associated with decrease of intracellular ATP and more with increase
in intracellular lactate levels and acidiﬁcation [32–35]. It seems that
lactate directly targets and activates KATP channels despite the
presence of high intracellular levels of ATP while low pH counteract
the channel inhibition induced by ATP [36]. It has been demonstrated,
at the both recombinant and native levels, that M-LDH physically
associated with KATP channels is required, by virtue of its catalytic
activity, for the channel opening during metabolic stress [4,5,9]. It has
been suggested that M-LDH-produced lactate 1) targets and activates
KATP channels and 2) decreases the channel sensitivity to inhibitory
effect of ATP [36,37]. At the same time M-LDH activity contributes to
the ATP production. The expression of 193glyM-LDH, a catalytically
inactive form of M-LDH, has been shown to inhibit both M-LDH
properties to activate KATP channels (by producing lactate) and
counteract DNP-induced decrease in subsarcolemmal ATP. Here, we
have shown that infection with 193glyM-LDH abolishes SUR2A-
mediated increase in K+ current as well as increase in subsarcolem-
mal ATP levels. This ﬁnding is in accord with our hypothesis that
infection with AV-SUR2A has increased the number of sarcolemmal
KATP channel protein complexes that are both important for
subsarcolemmal ATP levels and K+ current in response to metabolic
stress. An increase in subsarcolemmal ATP and KATP channel activation
might look as a contradiction. However, it is known that ischaemia
opens sarcolemmal KATP channels before the fall of intracellular ATP
occur [38], suggesting that the intracellular level of ATP is not the only
factor that regulates the channel activity. In addition to ATP, it has
been suggested that the activity of these channelsmay be regulated by
other nucleotides, intracellular pH, lactate, cytoskeleton, protein
kinase C, phosphatidylinositol-4,5-bisphosphate, and by the operative
condition of the channel itself [39]. It is well established that lactate
activates KATP channels in the presence of millimolar ATP, though the
mechanism of this activation is yet unknown [9]. Therefore, it is quite
possible that M-LDH catalytic activity results in both increase insubsarcolemmal ATP (the effect of ATP production) and KATP channel
activity (the effect of lactate production). How signiﬁcant is increase
in subsarcolemmal ATP for SUR2A-mediated cell survival was
assessed by comparing the effect of DNP in cell expressing SUR2A/
Kir6.2AFA (inhibited channel activity without changes in subsarco-
lemmal ATP) and cells expressing SUR2A/193glyM-LDH (inhibited
channel activity as well as increase in subsarcolemmal ATP). It has
been found that, unlike Kir6.2AFA, expression of 193glyM-LDH
abolished cytoprotection induced by SUR2A and had a deleterious
effect on cell survival under DNP. The fact that 193glyM-LDH was
more efﬁcient in inhibiting SUR2A than Kir6.2AFA supports our
hypothesis that infection of H9C2 cells with AV-SUR2A led to
increased numbers of sarcolemmal KATP channels, increase in
subsarcolemmal ATP and increased K+ current in response to
metabolic stress. An increase in subsarcolemmal ATP following
infection with SUR2A seems to be the major mechanism of SUR2A-
mediated cardioprotection. It is also worthwhile mentioning that cell
survival after concomitant infection with SUR2A and Kir6.2 was not
statistically different from those in cells infected with SUR2A alone.
This is compatible with idea that SUR2A level is the rate limiting factor
in regulating numbers of sarcolemmal KATP channels and cell
resistance to metabolic stress.
In conclusion, this study has shown that infection with SUR2A
increases resistance to metabolic stress in H9C2 cells. The mechanism
underlying SUR2A-mediated cytoprotection is associated with in-
crease in number of sarcolemmal KATP channels, increased K+ current
as well as increased production of ATP by the glycolytic enzymes
physically associated with KATP channel subunits.
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